Latest drug development News | Page 2

Pharmaxis announces the publication of positive preclinical data for PXS-5505
Monash University and Moderna form partnership to advance homegrown mRNA medicines
New tech is step towards lab-grown blood vessels
Funding for research into repairing a damaged heart
Beyfortus approved in the US for the prevention of RSV lower respiratory tract disease in infants
Economic life of cells
Baylor, Moroccan Ministry of Health and Social Protection and others collaborate to advance health in Africa
Rainforest plant could hold key to lung fibrosis treatment
Towards Synthesis of Phenanthridine-Based Pharmaceutical Compounds
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
New venom discovery from deadly cone snails
University joins European precision cancer medicine trial consortium
PolyU research discovers pathogenic mechanism and novel treatment for superbug “Klebsiella pneumoniae” to reduce mortality
Nirsevimab unanimously recommended by FDA Advisory Committee for the prevention of RSV lower respiratory tract disease in infants
New Musculoskeletal Genomics Group Leader joins Mater Research
Kazia Therapeutics participates in ‘Cancer Moonshot Brain Cancers’ forum
AI drug discovery will power collaboration with Pharos Therapeutics
KAZIA CEO, DR JOHN FRIEND PARTICIPATES IN WHITE HOUSE CANCER MOONSHOT FORUM Brain Cancers Forum on Glioblastoma & Diffuse Intrinsic Pontine Glioma Forum
SAiGENCI recruit recognised with prestigious award
LBT Innovations begins search for new board chair
Popular fertility apps are engaging in widespread misuse of data, including on sex, periods and pregnancy
Top talent to boost cancer research
In search of inflammatory Achilles heel
Industry and Science Minister Ed Husic’s Welcome speech to Science Meets Parliament 2023
Cornell-developed anti-TB compound headed to trials
The Next Pandemic: Researchers Develop Tool to Identify Existing Drugs to Use in a Future Outbreak
Record SA representation at global biotech event
Differences in animal biology can affect cancer drug development
On-demand male contraceptive shows promise in preclinical study
New conversations series to explore big questions and new frontiers
What we can learn from the Ozempic shortage
Ashurst advises Perspix Biotech on market entry in AI-driven drug development
Monash University and Ono Pharmaceutical Announce Collaboration Agreement
Demand booms for experimental mRNA from UQ BASE
New method finds right treatment for breast cancer patients
Artificial DNA kills cancer
Scientists Create Conditions for Stem Cell Growth Similar to Human Embryos
Scientists use materials to make stem cells behave like human embryos
Wisner ’16 shares expertise with entrepreneurial community
Gene therapy offers hope for severe epilepsy
NHMRC awards Ideas Grants to Garvan researchers
Efficient Synthesis of -Quinine Paves Way for Malarial Drug Development and More
Novotech awarded Asia Pacific CRO of Year 2022 for ‘Best Practices in Clinical Trials’
“We have to do a better job of utilizing our own ideas”
Griffith joins $280 million partnership to deliver mRNA vaccine outcomes
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
Offshoot of cells visualized in real time
Australian doctors lead world-first cancer trial to treat rare leukaemia